ESM1 promotes fatty acid synthesis and angiogenesis in ovarian cancer through the PKM2-dependent Warburg effect within a hypoxic TME, while shikonin effectively disrupts the interaction between ESM1 and PKM2, subsequently inhibiting glycolysis, fatty acid synthesis, and angiogenesis in ovarian cancer (70). Here, ESM1 is linked to ovarian carcinoma.